| __timestamp | Bio-Techne Corporation | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 20140000 |
| Thursday, January 1, 2015 | 119401000 | 37173000 |
| Friday, January 1, 2016 | 140879000 | 48616000 |
| Sunday, January 1, 2017 | 199243000 | 108488000 |
| Monday, January 1, 2018 | 240636000 | 244622000 |
| Tuesday, January 1, 2019 | 264359000 | 287000000 |
| Wednesday, January 1, 2020 | 260583000 | 354000000 |
| Friday, January 1, 2021 | 324951000 | 186000000 |
| Saturday, January 1, 2022 | 372766000 | 151000000 |
| Sunday, January 1, 2023 | 378378000 | 232600000 |
| Monday, January 1, 2024 | 396826000 | 267474000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Bio-Techne Corporation and Ionis Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Bio-Techne's SG&A expenses surged by over 550%, reflecting a strategic expansion and increased operational activities. In contrast, Ionis Pharmaceuticals experienced a more volatile pattern, with a peak in 2020, where their SG&A expenses were approximately 36% higher than Bio-Techne's. However, by 2023, Ionis's expenses had decreased by about 34% from their 2020 peak, indicating a possible shift in their operational strategy. Notably, data for 2024 is incomplete, highlighting the need for ongoing analysis. These insights provide a window into the financial health and strategic priorities of these biotech giants.
Zoetis Inc. and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Comparing SG&A Expenses: Bio-Techne Corporation vs Corcept Therapeutics Incorporated Trends and Insights
Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Vericel Corporation
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Halozyme Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. vs Opthea Limited: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. vs Merus N.V.: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared